[1] MICHAEL E. HALL John M S Francis Miley. The role of enzymatic processing in the biological actions of substance P[J]. Peptides, 1989, 10 4: Pages 895-901. DOI:
10.1016/0196-9781(89)90132-0[2] A T MICHAEL-TITUS. N- and C-terminal substance P fragments: differential effects on striatal [3H]substance P binding and NK1 receptor internalization.[J]. Neuroreport, 1999, 10 10: 2209-2213. DOI:
10.1097/00001756-199907130-00038[3] MARIO HERRERA-MARSCHITZ . The substance P(1–7) fragment is a potent modulator of substance P actions in the brain[J]. Brain Research, 1990, 521 1: Pages 316-320. DOI:
10.1016/0006-8993(90)91558-x[4] JULIE S. KREEGER Alice A L. Substance P-(1–7), a substance P metabolite, inhibits withdrawal jumping in morphine-dependent mice[J]. European journal of pharmacology, 1993, 238 1: Pages 111-115. DOI:
10.1016/0014-2999(93)90513-h[5] ANNA CARLSSON . Substance P1–7 induces antihyperalgesia in diabetic mice through a mechanism involving the naloxone-sensitive sigma receptors[J]. European journal of pharmacology, 2010, 626 2: Pages 250-255. DOI:
10.1016/j.ejphar.2009.10.006[6] JOÃO E DE ARAÚJO Marcus L B Joseph P Huston. Opposite effects of substance P fragments C (anxiogenic) and N (anxiolytic) injected into dorsal periaqueductal gray[J]. European journal of pharmacology, 2001, 432 1: Pages 43-51. DOI:
10.1016/s0014-2999(01)01460-1